mmc2025 draws strong abstract submissions
With more than 380 abstracts submitted, the Microscience Microscopy Congress 2025 (mmc2025), incorporating EMAG 2025, is set to be a landmark event in the world of microscopy and imaging. Taking place from 1–3 July at the Manchester Central conference centre, the overwhelming response from the scientifi c community guarantees an action-packed conference, featuring a diverse range of speakers and presentations across various fi elds, including microscopy, imaging, and Flow Cytometry.
The 385 submitted abstracts will be complemented by 54 invited speakers, further enriching the conference’s program. In total, the event will showcase over 400 oral and poster presentations, making it one of the largest gatherings in its fi eld.
Sali Davis, Chief Executive of RMS, expressed appreciation for the community’s support: “We are incredibly grateful to everyone who has submitted an abstract for mmc2025. This year’s event is shaping up to be a fantastic experience, with an incredible breadth of scientifi c content. We look forward to welcoming all attendees to Manchester Central this summer.”
Although the deadline for regular abstract submissions has passed, authors can still submit ‘late breaking’ abstracts for talks or posters.
More information online:
ilmt.co/PL/x57n 64377pr@reply-direct.com
Acquisition to advance imaging and research solutions
Leica Microsystems, renowned for its cutting-edge microscopy and imaging technologies, has announced the acquisition of ATTO- TEC, a key player in the development of specialty fl uorescent dyes and reagents. This acquisition strengthens Leica’s ability to offer a complete microscopy imaging workfl ow, further supporting researchers in a range of scientifi c fi elds.
The integration of ATTO-TEC’s high-performance dyes and reagents with Leica’s advanced microscopy platforms, AI-based analysis tools, and imaging solutions is expected to streamline research processes and boost the accuracy of results. This acquisition is particularly timely, as researchers increasingly focus on complex, high-plex 3D experiments in areas such as cancer research.
Dr Annette Rinck, President of Leica Microsystems, highlighted the strategic value of this acquisition: “By bringing ATTO-TEC’s expertise into our portfolio, we can now support every aspect of the microscopy imaging workfl ow. This integrated approach will deliver more reliable outcomes and accelerate discoveries that can contribute to advancing medical therapies.”
ATTO-TEC is widely recognised for its high-quality products,
including their signature fl uorescent dyes like ATTO 488 and ATTO 647N, which have become standards in fl uorescence microscopy. Known for their exceptional brightness and photostability, these dyes are critical for applications that demand precision and clarity. The company’s suite of products also includes antibody labelling kits and phospholipids, which will continue to be offered through ATTO-TEC’s online platform and existing distribution channels.
Dr Jörg Reichwein, CEO of ATTO-TEC, expressed enthusiasm about the merger, stating, “Joining Leica Microsystems allows us to integrate our expertise with their industry-leading imaging technologies. Together, we can develop even more specialised assays, kits, and dyes, optimised for every stage of the imaging workfl ow.”
This acquisition marks a signifi cant step forward in Leica Microsystems’ mission to enable breakthrough research, enhance scientifi c discovery, and contribute to improving human health through advanced imaging technologies.
Super-resolution image of cleared zebrafish heart tissue. Sample Courtesy of Dr Mariano Gonzales Pisfil and Dr Steffen Dietzel from the Biomedical Centre at Ludwig-Maximilians- University Munich, Germany.
More information online:
ilmt.co/PL/89YK 64381pr@reply-direct.com
Light beam captures Alzheimer’s-linked proteins for new disease insights
Researchers at Nottingham Trent University are pioneering a groundbreaking study that uses high concentrations of light to examine the fast structural changes in single proteins linked to Alzheimer’s, offering new insights into the disease’s progression.
This fi rst-of-its-kind research aims to deepen understanding of the neurodegenerative process, which begins as much as 20 years before symptoms appear. By studying these early-stage changes, the team hopes to pave the way for early diagnosis and treatment of Alzheimer’s and other age- related neurodegenerative diseases.
Led by Dr Cuifeng Ying from the university’s Advanced Optics and Photonics group, the research is supported by the Academy of Medical Sciences. Dr Ying’s technique isolates and monitors the behaviour of single proteins in their natural environment without altering them, a crucial step forward in understanding how these proteins contribute to disease.
Proteins that aggregate abnormally in the brain are known to be a key factor in neurodegenerative diseases like Alzheimer’s. However, current technologies cannot track the motions and behaviour of these individual proteins without modifying them, which can hinder insights into their true functions.
The team’s novel technique overcomes this limitation by using a high concentration of light transmitted through an
engineered nanostructure. This creates enough force to ‘grasp’ and hold a single protein, which is far thinner than a strand of hair, within a fl uid without damaging it. By analysing how the light scatters, researchers can gather real-time data on how the protein behaves.
The study will use proteins extracted from fruit fl ies, which share a signifi cant portion of their genes with humans, to examine how these proteins change over different stages of the disease. The researchers will also explore how the proteins respond to various drug treatments.
With nearly 1 million people in the UK affected by dementia, a key symptom of late-stage Alzheimer’s, the research is vital. Alzheimer’s currently costs the UK nearly £35 billion annually, a fi gure projected to rise with the aging population.
“Innovative approaches are urgently needed to understand the triggers of these diseases, enabling earlier disease detection and treatment,” said Dr Ying. “By studying single proteins in their natural state, we can observe how they behave over time, providing critical insights into the onset of neurodegenerative
diseases and helping drive the development of earlier diagnoses and therapies.”
The research is funded through the Academy of Medical Sciences’ Springboard programme, in partnership
with
the Government’s Department for Science, Innovation and Technology, Wellcome, and the British Heart Foundation. UK
Dr Cuifeng Ying. Credit: Nottingham Trent University
Science Minister Lord Vallance emphasised the importance of such research in addressing major health challenges and supporting early-career researchers.
Through this work, the team hopes to reduce the number of people affected by neurodegenerative diseases and alleviate associated healthcare costs.
More information online:
ilmt.co/PL/Z6Dz 64415pr@reply-direct.com
T
What’s in the next issue? Find out with a copy of our Media Information Pack.
2
2
ILM MEDIA
sales@intlabmate.com
N 2 2 1
9 2
T
H
AUGUST / SEPTEMBER 2024 - VOLUME 25 ISSUE 4
50 5 VERIFIED FUELS MORE Learn more at
MSASafety.com/FL5000
One small footprint. One giant leap.
Introducing theHorizen 24 nitrogen generator for LCMS, combining PEAK performance and economy while helping you reduce your lab’s carbon footprint.
Save space with a 28% smaller footprint* Save money with reduced operating costs, lower heat output and minimal downtime Save the planet with up to 55% lower energy consumption**
partner
50 5 NEW
Connecting
Innovation for over 50 years 50 FL5000 MSIR Flame Detector 5 MARCH 2023 - VOLUME 48 ISSUE 2 N
Connecting Science,
THE WORLD’S FIRST ULTRA-LOW TEMPERATURE CHEST FREEZER
One small footprint. One giant leap.
Introducing the Horizen 24 nitrogen generator for LCMS, combining PEAK performance and economy while helping you reduce your lab’s carbon footprint.
Save space with a 28% smaller footprint*
Save money with reduced operating costs, lower heat output and minimal downtime Save the planet with up to 55% lower energy consumption**
Your local gas generation partner 50 5 NEW Innovation for over 50 years 30
Connecting Science, Bridging Innovation for over 50 years N
25 OVER
THE WORLD’S FIRST ULTRA-LOW TEMPERATURE CHEST FREEZER LAUDA Mobifreeze ºFAHRENHEIT. ºCLESIUS. ºLAUDA.
Connecting Science, Bridging Innovation for over 50 years
30
Measurement Analysis China Annual Buyers Guide 2023/2024年度 采购指南
Alphasense诚意推出 新系列高品质传感器
A+和 B+系列 智能传感器
主要特色
• 保证100% 无泄漏 • 耐温性和抗湿性比其他主流品牌高出10倍 • 受大气条件影响的程度至少降低3.5倍 依托 25 年氧气传感器制造技术创新 更换次数更少/仪器故障率更低 特征保持不变
100% 无泄漏 氧气传感器
H系列-划时代的 紧凑型传感器
主要特色
•可用于 9 种目标气体 •紧凑型设计，基于成熟的 D 系列规格优化而来 • 比传统规格小45% • 较行业标准轻65% • 可与类似规格传感器互换
N
1
1
1
1
E
2 9
2 9
2
9
2
9
9 2
E
7
7
7
7
0
9
4
T
4
4
4
L
A
0
0
E
0
9
0
9
4
A
A
s
R
i
a
n
T
E
I
N
N
G
V
A
O
I
3
L
L
G
R
5
O
O
O
N
L
V
N 2
H
O
M
I
L
C
M
0
6
T
Y
2
0
N
0
2
E
2
I
N
T
E
N
A
O
C
R
E
O
1 5
Y
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
